[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356015-105":59,"doc-detail-356015-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","lysops-gpr34-axis-enhances-tumor-associated-macrophages-efferocytosis-to-promote-immune-escape-in-gastric-cancer-peritoneal-metastasis","LysoPS-GPR34 axis enhances tumor-associated macrophages efferocytosis to promote immune escape in gastric cancer peritoneal metastasis","","Metabolites shape the immunosuppressive tumor microenvironment (TME) and drive immune evasion in cancer. Lysophosphatidylserine (LysoPS), a key lysophospholipid signaling molecule, correlates with advanced disease in multiple tumor types, yet its role in gastric cancer peritoneal metastasis remained unclear. Single-cell transcriptomic profiling, histology, and functional in vivo work define how LysoPS reprograms tumor-associated macrophages via GPR34 to enhance efferocytosis, IL-10 and TGF-β secretion, and PD-1+ T cell accumulation. Pharmacologic GPR34 inhibition also potentiates anti-PD-1 therapy, synergistically suppressing tumor growth.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lysops-gpr34-axis-enhances-tumor-associated-macrophages-efferocytosis-to-promote-immune-escape-in-gastric-cancer-peritoneal-metastasis/356015/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lysops-gpr34-axis-enhances-tumor-associated-macrophages-efferocytosis-to-promote-immune-escape-in-gastric-cancer-peritoneal-metastasis/356015.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does this study address in gastric cancer peritoneal metastasis?","Question",{"text":113,"@type":114},"The study addresses how LysoPS contributes to peritoneal metastasis by shaping an immunosuppressive TME and promoting immune evasion, a mechanism previously not clearly defined.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the role of the LysoPS–GPR34 axis investigated?",{"text":118,"@type":114},"The work used single-cell transcriptomic profiling, immunohistochemistry and multiplex immunofluorescence to validate GPR34-high TAMs, and molecular assays and in vivo models for functional validation.",{"name":120,"@type":111,"acceptedAnswer":121},"What does the LysoPS–GPR34 axis do to tumor-associated macrophages?",{"text":122,"@type":114},"LysoPS engagement of GPR34 activates ERK/c-Jun signaling, upregulates AXLand CD36 to enhance efferocytosis, and pushes TAMs toward an immunosuppressive phenotype with increased IL-10 and TGF-β secretion.",{"name":124,"@type":111,"acceptedAnswer":125},"How does GPR34 inhibition affect therapy outcomes?",{"text":126,"@type":114},"GPR34 inhibition reduces M2-like TAM infiltration, improves cytotoxic T cell recruitment, decreases PD-1+ T cell accumulation, and synergizes with anti-PD-1 therapy to better suppress tumor growth.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},356015,1790182052,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Open access Original research  \n LysoPS-GPR34 axis enhances tumor  \nassociated macrophages efferocytosis to promote immune escape in gastric cancer peritoneal metastasis  \nJialong Lv,1 Mingyue Zhang,1 Fan Xiang,1 Cheng Huang,1 Dianshi Wang,1 Kun He,1 Guanxin Wei,2 Xiang Chen,3 Danzeng He,1 Wenhao Wen,4 Kaixiong Tao,1,2 Chuanqing Wu  1  \nTo cite: Lv J, Zhang M, Xiang F, et al. LysoPS-GPR34 axis enhances tumor-associated macrophages efferocytosisto promote immune escape in gastric cancer peritoneal metastasis. Journal for ImmunoTherapy of Cancer 2026;14:e015464 . doi:10 . 1136/ jitc-2026-015464  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2026-015464](jitc-2026-015464)) .  \nJL, MZ and FX contributed equally.  \nAccepted 06 July 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Chuanqing Wu; [wucq2014@hust.edu.cn](wucq2014@hust.edu.cn)  \nABSTRACT  \nBackground Metabolites sculpt the immunosuppressive tumor microenvironment (TME) that facilitates immune evasion. As a crucial signaling lysophospholipid, lysophosphatidylserine (LysoPS) correlates with advanced disease stages in multiple tumor types. However, the mechanisms by which LysoPS drives gastric cancer peritoneal metastasis remain undefined.  \nMethods Single-cell transcriptomic profiling of primary tumors, normal peritoneum, and metastatic lesions delineated mechanisms underlying LysoPS-mediated tumor-associated macrophages (TAMs) reprogramming. Immunohistochemistry and multiplex immunofluorescence validated GPR34-high TAMs infiltration in peritoneal metastases. Functional validation was performed using molecular assays and in vivo models.  \nResults LysoPS accumulated in ascites from patients with gastric cancer peritoneal metastasis, establishing an immunosuppressive TME that drove malignant progression. Using single-cell transcriptome sequencing, we identified a distinct subset of TAMs highly expressing GPR34 enriched in gastric cancer peritoneal metastases, which correlates with tumor progression and immune evasion. Mechanistically, LysoPS engagement of GPR34 activated ERK/c-Jun signaling, transcriptionally upregulating AXLand CD36 to enhance efferocytosis. This effect drove TAMs toward an immunosuppressive phenotype, characterized by enhanced interleukin-10 and transforming growth factor-β secretion. GPR34 inhibitor attenuated M2-like TAMs infiltration while bolstering cytotoxic T cells recruitment and curtailing programmed cell death protein 1 (PD-1)+T cells accumulation. Furthermore, combination with anti-PD-1 therapy synergistically suppressed tumor growth beyond monotherapy efficacy.  \nConclusions LysoPS-GPR34 axis synergized withefferocytosis to amplify TAMs immunosuppressive properties, fostering an immune-evasive microenvironment; GPR34 inhibitor thus represents a promising strategy to potentiate PD-1 blockade efficacy in gastric cancer peritoneal metastasis.  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ Lysophosphatidylserine (LysoPS) is an emerging lipid signaling molecule that activates downstream signaling pathways by binding to its receptors (GPR34, GPR174, P2RY10) and is involved in the progression of various tumors. Although LysoPS is enriched in the ascites of patients with gastric cancer, its relationship with peritoneal metastasis of gastric cancer and the underlying mechanisms remain unclear.\u003Cbr>WHAT THIS STUDY ADDS |\n| ⇒ LysoPS is significantly enriched in the ascites of patients with gastric cancer with peritoneal metastasis and is closely associated with the progression of peritoneal metastasis.\u003Cbr>⇒ A population of tumor-associated macrophages (TAMs) with high expression of GPR34 is present in gastric cancer peritoneal meta","cbCairrE70IiMl0P","https://ap.wps.com/l/cbCairrE70IiMl0P","pdf",10884227,"English","# Background\n# Methods\n# Results\n# Conclusions\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy\n# Introduction","[{\"question\":\"What problem does this study address in gastric cancer peritoneal metastasis?\",\"answer\":\"The study addresses how LysoPS contributes to peritoneal metastasis by shaping an immunosuppressive TME and promoting immune evasion, a mechanism previously not clearly defined.\"},{\"question\":\"How was the role of the LysoPS–GPR34 axis investigated?\",\"answer\":\"The work used single-cell transcriptomic profiling, immunohistochemistry and multiplex immunofluorescence to validate GPR34-high TAMs, and molecular assays and in vivo models for functional validation.\"},{\"question\":\"What does the LysoPS–GPR34 axis do to tumor-associated macrophages?\",\"answer\":\"LysoPS engagement of GPR34 activates ERK/c-Jun signaling, upregulates AXLand CD36 to enhance efferocytosis, and pushes TAMs toward an immunosuppressive phenotype with increased IL-10 and TGF-β secretion.\"},{\"question\":\"How does GPR34 inhibition affect therapy outcomes?\",\"answer\":\"GPR34 inhibition reduces M2-like TAM infiltration, improves cytotoxic T cell recruitment, decreases PD-1+ T cell accumulation, and synergizes with anti-PD-1 therapy to better suppress tumor growth.\"}]","LysoPS-GPR34 axis enhances tumor-associated macrophages efferocytosis to promote immune escape in gastric cancer peritoneal metastasis | PDF",1790122352,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0826b736cf8825515d3c5a10fd6b6ff8.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02aae6c5f1192d9e0b5f5c48a0714a77.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0de0f6bfa7cd3e52c8128a73eba608e.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a39615472d82a1e6e1b3cfd469a21df5.webp",980,1306]